Search

everythinglearnresearchcommunity

for

Search:↓

Extracellular vesicles show promise for treating psoriasis by reducing inflammation and skin lesions.

Certain metabolites can either protect against or increase the risk of hair loss.

Higher levels of certain DNAs in blood may indicate hair follicle damage in alopecia areata patients.

People with androgenetic alopecia have different lipid levels in their blood, which vary between men and women, and may be linked to a higher risk of metabolic syndrome.

The research suggests that immune cells and a specific type of cell death called ferroptosis are involved in Frontal fibrosis alopecia.

Hair proteins in preschool children and their mothers could indicate developmental changes and health status.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

Hair follicle sampling is a practical method for measuring biomarkers in children with and without Fragile X syndrome.

Mothers have more hair proteins than their children, with age-related differences in protein patterns, and some proteins in hair could indicate early childhood development.

People with pattern hair loss have higher polyamine levels in the top of their head compared to the back.

Researchers discovered potential origins and new treatments for skin cancer, including biomarkers for melanoma and therapies that reduce tumor growth.

Hair growth pathways are a promising and simpler method for detecting chronic stress.

Urban air pollution worsens hair loss in alopecia areata by increasing immune response.

Certain N-glycans may help assess hair loss severity in men with female-pattern hair loss.

miR-155-5p can help diagnose and track alopecia areata severity.

Fractional CO2 laser therapy effectively improves skin conditions and recovery when combined with other treatments.

Three genes, BMP4, POSTN, and WNT5A, may help treat keloids.

Skin diseases like alopecia areata and psoriasis may be linked to blood clotting issues and heart problems.

Male and female pattern hair loss have different molecular pathways, suggesting unique treatment targets for each sex.

SFRP2 and PTGDS may be key factors in female hair loss.

Exosomes show promise for diagnosing and treating skin conditions and hair loss.

The research suggests that SFRP2 and PTGDS proteins might be indicators of female pattern hair loss and could contribute to hair loss.

Early baldness and little chest hair may indicate higher prostate cancer risk.

The PROCLIPI study found markers that help predict outcomes in skin lymphoma patients.

Exosomes show promise for tissue repair and regeneration with advantages over traditional cell therapies.

Certain miRNAs might be involved in a hair loss condition called frontal fibrosing alopecia and could possibly help in its diagnosis.

The conclusion is that a more comprehensive and precise approach is needed for diagnosing PCOS to address its broader health risks.

Certain enzymes and a growth factor were higher in mice treated with minoxidil or a peppermint and rosemary oil mix, which may be good indicators of hair growth.

In vitro methods for testing cosmeceuticals need improvement for better human relevance and reliability.

Androgenetic alopecia is linked to higher cardiovascular and metabolic risks, possibly due to irisin resistance.